Generative AI In Drug Discovery And India’s Potential To Leapfrog

Heads of Novartis Biomedical, World Economic Forum and Indian majors like Sun Pharma’s SPARC, among others, discuss generative AI in drug discovery along with pointers for India to leapfrog the R&D process

AI's Role In Drug Discovery Is Expanding
AI's Role In Drug Discovery Is Expanding (Shutterstock)

As artificial intelligence (AI) gets more deeply embedded into the drug discovery systems of global pharma majors, an increasing number of use cases continue to emerge, some with the potential to shake the very foundations of how things have traditionally been done and others with more peripheral applications.

Late last week, VantAI - Roivant Sciences’s AI-enabled drug discovery unit - launched Neo-1, an AI model to unify de...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Strategy